Health Condition 1: Q355- Cleft hard palate with cleft softpalate Health Condition 2: Q359- Cleft palate, unspecified
Conditions
Interventions
Intervention1: DEXMEDETOMIDINE: intravenously inj.Dexmeditomidine 1 ug/kg over 10 minutes, followed by 0.3 ug/kg/hour is given.
And infusion will be stopped 30 minutes prior to completion of cleft pa
Sponsors
DR D Y PATIL MEDICAL COLLEGE AND HOSPITAL AND RESEARCH CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: •ASA grade I or II fit patients. •Patients between 6 months to 6 years of age scheduled to undergo primary or secondary cleft repair. •Weight 5 â?? 20 kilograms.
Exclusion criteria
Exclusion criteria: 1.Patients with any other congenital abnormalities with difficult airways. 2.Patients with any cognitive impairment. 3.Patients with history of allergy, hypersensitivity or contraindication to any drug used for anaesthesia including opioids like morphine, fentanyl, hydrocodone and inhalation agents i.e. children with susceptibility to malignant hyperthermia. 5.Bleeding disorders like e.g. hemophilia or any active clinically significant bleeding. 6.Patients with impaired renal or hepatic function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| study the effect of Dexmeditomidine on intra operative hemodynamic parametersTimepoint: 5 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Duration of postoperative analgesia. 2.Post operative recovery score and emergence delirium. Timepoint: 6 months. | — |
Countries
India
Contacts
Public ContactDR SONAL KHATAVKAR
DEPARTMENT OF ANESTHESIOLOGY,DR.D.Y.PATIL MEDICAL COLLEGE AND HOSPITAL AND RESEARCH CENTRE
Outcome results
None listed